NEW YORK, June 7, 2016 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) concerning possible violations of federal securities laws.
On May 19, 2016, news outlets reported that a Massachusetts federal jury had awarded a $70 million verdict to Neovasc's rival, CardiAQ Valve Technologies Inc., finding that Neovasc had stolen trade secrets from CardiAQ. To obtain additional information about the investigation, go to:
http://zlk.9nl.com/neovasc-nvcn
or contact Eduard Korsinsky, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
SOURCE Levi & Korsinsky, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article